Johnson & Johnson announced the submission of a supplemental New Drug Application (sNDA) to the FDA seeking to expand the indication of Prezcobix (darunavir/cobicistat) to include the treatment… read more.
A new study to be presented at the SLEEP 2024 annual meeting found a distinct relationship between sleep duration, social media usage, and brain activation across brain regions… read more.
Effective use of standardised products in neonatology depends on expert knowledge of both the clinical situation and the pharmaceutics of the products – and this is where prescribing… read more.
A parenteral nutrition solution contains about 50 different components and is critical for survival and growth of a pre-term infant. Managing such products requires a good understanding of… read more.
Steve Tomlin is a pharmacist and Director of the Children’s Medicines Research and Innovation Centre (CMRIC) at Great Ormond Street Hospital for Children in London. His mission is… read more.
A quarter of parents report that caffeine is basically part of their teen’s daily life, according to a national poll. Two in three parents think they know whether… read more.
The implementation of primary health care (PHC) over the last two decades has prevented more than 300,000 child deaths in four Latin American countries, and could prevent more than 140,000 by 2030 in a… read more.
Electronic vapor products (EVPs), also known as e-cigarettes or vaping devices, have an allure because of their marketed image as a safer alternative to traditional cigarette smoking and… read more.
UCB announced the final three-year open-label extension (OLE) study results of Fintepla (fenfluramine) in Dravet syndrome are being presented at the International Child Neurology Congress (ICNC), May 6-10,… read more.
Australian researchers have discovered how changes in antibody levels over time can predict which children are likely to outgrow their peanut allergy. The research, led by Murdoch Children’s Research… read more.
Resident physicians at more than 98% of U.S. training programs aren’t paid enough to afford childcare, according to a new national study. The research will be presented at… read more.
Novartis announced that the FDA approved Lutathera (USAN: lutetium Lu 177 dotatate / INN: lutetium (177Lu) oxodotreotide) for the treatment of pediatric patients 12 years and older with… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
